Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Down-regulation of RIP1 by 2-deoxy-D-glucose sensitizes breast cancer cells to TRAIL-induced apoptosis.

Huang YY, Liu H, Li Y, Pu LJ, Jiang CC, Xu JC, Jiang ZW.

Eur J Pharmacol. 2013 Apr 5;705(1-3):26-34. doi: 10.1016/j.ejphar.2013.02.005. Epub 2013 Mar 7.

PMID:
23499682
2.

[2-DG enhances TRAIL-induced apoptosis of leukemia HL-60 cells].

Zhao SR, Duan HF, Zhang P, Liu H, Jiang CC, Jiang ZW.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Apr;21(2):351-5. doi: 10.7534/j.issn.1009-2137.2013.02.019. Chinese.

PMID:
23628031
3.

MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.

Azijli K, Yuvaraj S, van Roosmalen I, Flach K, Giovannetti E, Peters GJ, de Jong S, Kruyt FA.

Apoptosis. 2013 Jul;18(7):851-60. doi: 10.1007/s10495-013-0829-3.

PMID:
23456625
4.

[Glycosylation inhibitor 2-deoxy-D-glucose sensitizes oral cancer cells to TRAIL-induced apoptosis].

Xu J, Huang Y, Li Y, Pu L, Xia F, Jiang C, Liu H, Jiang Z.

Nan Fang Yi Ke Da Xue Xue Bao. 2013 Apr;33(4):524-7. Chinese.

5.

RIP1 is required for IAP inhibitor-mediated sensitization for TRAIL-induced apoptosis via a RIP1/FADD/caspase-8 cell death complex.

Abhari BA, Cristofanon S, Kappler R, von Schweinitz D, Humphreys R, Fulda S.

Oncogene. 2013 Jul 4;32(27):3263-73. doi: 10.1038/onc.2012.337. Epub 2012 Aug 13.

PMID:
22890322
6.

Suppression of HSP70 expression sensitizes NSCLC cell lines to TRAIL-induced apoptosis by upregulating DR4 and DR5 and downregulating c-FLIP-L expressions.

Zhuang H, Jiang W, Zhang X, Qiu F, Gan Z, Cheng W, Zhang J, Guan S, Tang B, Huang Q, Wu X, Huang X, Jiang W, Hu Q, Lu M, Hua ZC.

J Mol Med (Berl). 2013 Feb;91(2):219-35. doi: 10.1007/s00109-012-0947-3. Epub 2012 Sep 5.

PMID:
22948392
8.

2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2.

Liu H, Jiang CC, Lavis CJ, Croft A, Dong L, Tseng HY, Yang F, Tay KH, Hersey P, Zhang XD.

Mol Cancer. 2009 Dec 14;8:122. doi: 10.1186/1476-4598-8-122.

9.

Down-regulation of c-FLIP Enhances death of cancer cells by smac mimetic compound.

Cheung HH, Mahoney DJ, Lacasse EC, Korneluk RG.

Cancer Res. 2009 Oct 1;69(19):7729-38. doi: 10.1158/0008-5472.CAN-09-1794. Epub 2009 Sep 22.

10.

TWEAK induces apoptosis through a death-signaling complex comprising receptor-interacting protein 1 (RIP1), Fas-associated death domain (FADD), and caspase-8.

Ikner A, Ashkenazi A.

J Biol Chem. 2011 Jun 17;286(24):21546-54. doi: 10.1074/jbc.M110.203745. Epub 2011 Apr 27.

11.

Curcumin enhances TRAIL-induced apoptosis of breast cancer cells by regulating apoptosis-related proteins.

Park S, Cho DH, Andera L, Suh N, Kim I.

Mol Cell Biochem. 2013 Nov;383(1-2):39-48. doi: 10.1007/s11010-013-1752-1. Epub 2013 Jul 12.

PMID:
23846485
12.

Inhibition of the ubiquitin-proteasome system sensitizes TRAIL-resistant prostate cancer cells by up-regulation of death receptor 5.

Lee YJ, Seol JW, Jeong JK, Moon MH, Park SY.

Mol Med Rep. 2011 Nov-Dec;4(6):1255-9. doi: 10.3892/mmr.2011.558. Epub 2011 Aug 16.

PMID:
21850375
13.

Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells.

Yoshida T, Zhang Y, Rivera Rosado LA, Zhang B.

Mol Cancer Res. 2009 Nov;7(11):1835-44. doi: 10.1158/1541-7786.MCR-09-0244. Epub 2009 Oct 20.

14.

Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells.

Wang P, Zhang J, Bellail A, Jiang W, Hugh J, Kneteman NM, Hao C.

Cell Signal. 2007 Nov;19(11):2237-46. Epub 2007 Jun 21.

PMID:
17693058
15.

TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways.

Zhang L, Dittmer MR, Blackwell K, Workman LM, Hostager B, Habelhah H.

Cell Signal. 2015 Feb;27(2):306-14. doi: 10.1016/j.cellsig.2014.11.014. Epub 2014 Nov 18.

16.

The dietary flavonol fisetin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells.

Szliszka E, Helewski KJ, Mizgala E, Krol W.

Int J Oncol. 2011 Oct;39(4):771-9. doi: 10.3892/ijo.2011.1116. Epub 2011 Jul 6.

PMID:
21743964
17.

Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis.

Geserick P, Drewniok C, Hupe M, Haas TL, Diessenbacher P, Sprick MR, Schön MP, Henkler F, Gollnick H, Walczak H, Leverkus M.

Oncogene. 2008 May 15;27(22):3211-20. Epub 2007 Dec 17.

PMID:
18084329
18.

Seleno-cyclodextrin sensitises human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression.

Lin T, Ding Z, Li N, Xu J, Luo G, Liu J, Shen J.

Eur J Cancer. 2011 Aug;47(12):1890-907. doi: 10.1016/j.ejca.2011.04.004. Epub 2011 May 10.

PMID:
21565489
19.

Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.

Allensworth JL, Sauer SJ, Lyerly HK, Morse MA, Devi GR.

Breast Cancer Res Treat. 2013 Jan;137(2):359-71. doi: 10.1007/s10549-012-2352-6. Epub 2012 Dec 7.

PMID:
23225169
20.

2-Tellurium-bridged β-cyclodextrin, a thioredoxin reductase inhibitor, sensitizes human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-κB suppression.

Lin T, Ding Z, Li N, Xu J, Luo G, Liu J, Shen J.

Carcinogenesis. 2011 Feb;32(2):154-67. doi: 10.1093/carcin/bgq234. Epub 2010 Nov 16.

PMID:
21081474

Supplemental Content

Support Center